The availability of targeted therapies is beginning to allow for personalized treatment in advanced prostate cancer. Several abstracts related to m......READ MORE
Advancements in imaging and the identification of clinical and genomic risk factors are improving the treatment of patients with high-risk localize......READ MORE
Prostate-specific membrane antigen (PSMA) has emerged as a preeminent prostate cancer target for diagnostic imaging. Additionally, as seen at the 2......READ MORE
Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, ......READ MORE
Among the reports featured at AES2020 were updates on several registries in populations that may be affected by drug-resistant epilepsies. These an......READ MORE
Numerous real-world studies and post hoc analyses on drug-resistant epilepsy were presented at AES2020. These presentations expand our knowledge of......READ MORE
